✦ LIBER ✦

Altered bile acid metabolism in benign recurrent intrahepatic cholestasis (BRIC)

✍ Scribed by Kobayashi, Y.; Moussa, I.; De Gregorio, J.; Reimers, B.; Di Mario, C.; Finci, L.; Colombo, A.

Book ID: 122401102
Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 76 KB
Volume: 7
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(88)80080-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abnormal hepatic bile acid transport is

Abnormal hepatic bile acid transport is not improved by ursodiol in benign recurrent intrahepatic cholestasis (BRIC)

✍ Jennifer Christie; Ed Barbarito; Ashok K. Batta; Ken Klein; Alex S. Knisely; Lau 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phenobarbital-induced alterations of bil

Phenobarbital-induced alterations of bile acid metabolism in cases of intrahepatic cholestasis

✍ Back, Peter 📂 Article 📅 1982 🏛 Springer-Verlag 🌐 English ⚖ 1011 KB

IS AN ACUTE DISTURBANCE IN HEPATIC TRANS

IS AN ACUTE DISTURBANCE IN HEPATIC TRANSPORT OF BILE-ACIDS THE PRIMARY CAUSE OF CHOLESTASIS IN BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS?

✍ Van Berge Henegouwen, G.P; Brandt, K.-H; De Pagter, A.G.F 📂 Article 📅 1974 🏛 The Lancet 🌐 English ⚖ 394 KB

Failure of ursodeoxycholic acid to preve

Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: A study of bile acid metabolism

✍ Andrea Crosigani; Mauro Podda; Emanuela Bertolini; Pier Maria Battezzati; Massim 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 820 KB

Therapeutic use of phenobarbital in intr

Therapeutic use of phenobarbital in intrahepatic cholestasis. Inductions in bile acid metabolism

✍ Peter Back 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Efficacy of ursodeoxycholic acid in prev

Efficacy of ursodeoxycholic acid in preventing cholestatic episodes in a patient with benign recurrent intrahepatic cholestasis

✍ Giuseppe Maggiore; Costantino de Giacomo 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

We read with interest the paper by Crosignani and colleagues (1) demonstrating the inefficacy of ursodeoxycholic acid (UDCA) in preventing cholestatic episodes in a patient with benign recurrent intrahepatic cholestasis (BRIC). We would like to report a different experience with a 24-yr-old woman af